An altered methylation pattern was detected in the promoters of ABCB1, ABCC1, and ABCG2 in breast and lung cancer, whereas the defective activity of histone acetylases including EP300, CBP, and PCAF was reported to be implicated in ABCB1 overexpression [37,38]. Here, EP300 is linked to lung cancer.